GORE VIABAHN VBX Balloon Expandable Endoprosthesis
W. L. Gore & Associates, Inc. · Decision date Oct 8, 2026
What did the FDA approve?
The FDA record lists PMA supplement P160021/S051 for the GORE® VIABAHN® VBX Balloon Expandable Endoprosthesis, filed by W. L. Gore & Associates, Inc., with a decision date of 2026-10-08 and decision code APPR. The supplement type is Panel Track, and the reason given is a labeling change covering indications or instructions, shelf life, or tradename. The product code is PRL, described as an iliac covered stent, arterial, in the cardiovascular specialty.
The supplied statement describes the change as expanding the indications to include use as a bridging stent to maintain visceral artery perfusion in fenestrated and branched endovascular aortic aneurysm repair, abbreviated FEVAR and BEVAR. The identifier places this supplement under the original PMA P160021, but the record does not establish a new approval of the whole system. The statement reports the stated purpose of the labeling expansion and does not by itself provide evidence of safety or clinical effectiveness.
FDA approval order statement
expanding the indications to include use as a bridging stent to maintain visceral artery perfusion in fenestrated and branched endovascular aortic aneurysm repair (FEVAR and BEVAR)
- Regulatory pathway
- PMA supplement
- Supplement type
- Panel Track
- Clinical specialty
- Cardiovascular
- Decision date
- Oct 8, 2026
- FDA change category
- Labeling Change - Indications/instructions/shelf life/tradename
FDA source record · MedtechLedger’s explanation describes the recorded change.
Regulatory record facts
- Identifier
- P160021/S051
- Regulatory pathway
- PMA supplement
- Applicant
- W. L. Gore & Associates, Inc.
- Product code
- PRL
- Decision code
- APPR
- Decision date
- Oct 8, 2026
- Source update
- Nov 9, 2026
- Original record
- Open FDA source record
About this medical device
FDA device category: Iliac covered stent, arterial.
- Applicant
- W. L. Gore & Associates, Inc.
- Product code
- PRL
- FDA device class
- 3
For the original device and its historical approval scope, see PMA P160021. Subsequent supplements may change the device or its indications.
FDA decision timeline
P160021 · Original PMA
GORE VIABAHN VBX BALLOON EXPANDABLE ENDOPROSTHESIS
P160021/S051 received
Application receipt date recorded by FDA.
P160021/S051 · FDA decision
Panel Track
Timeline entries are records held by MedtechLedger for P160021. View FDA’s full supplement list.
Related devices and submissions
Same PMA: P160021
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
| W. L. Gore & Associates, Inc. | PMA approval | Jan 27, 2017 | FDA |
Regulatory context
A PMA supplement records a change to a device with an existing premarket approval. The supplement’s approval applies to the change described in that submission.
Read our guide to FDA clearance and approval · FDA’s explanation of this pathway
Manufacturer intelligence
W. L. Gore & Associates, Inc.
- Headquarters
- Not reported
- Brand website
- Not reported
- FDA applicant address
- 3250 W. Kiltie Ln., Flagstaff, AZ, 86005
Sources and methodology
- Original FDA record: P160021/S051
- openFDA source data · Source release Nov 9, 2026 · Retrieved Nov 19, 2026
FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.
How we use FDA records